This content is only available within our institutional offering.
26 Jul 2018
LIBERUM: Roche - 9% EBIT beat, guidance upgrade and positive pipeline developments
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Roche - 9% EBIT beat, guidance upgrade and positive pipeline developments
Roche Holding Ltd Dividend Right Cert. (RHO5:ETR) | 0 0 1.1% | Mkt Cap: 194,207m
- Published:
26 Jul 2018 -
Author:
Graham Doyle -
Pages:
3